Medium-chain triglyceride (MCT) diet in intractable seizure disorders

Area of Science:

• Neurology
• Dietary Therapy
• Epilepsy Management

Background:

• Intractable seizures pose significant challenges in pediatric epilepsy.
• Conventional antiepileptic drugs are often insufficient for complete seizure control.
• Alternative therapeutic strategies are crucial for managing difficult-to-treat epilepsy.

Purpose of the Study:

• To evaluate the efficacy and tolerability of the medium-chain triglyceride (MCT) diet in pediatric patients with intractable seizures.
• To assess the impact of the MCT diet on seizure frequency and the need for anticonvulsant medications.

Main Methods:

• A cohort of 17 pediatric patients with intractable seizures, aged 12 months to 13 years, were enrolled.
• Patients received the medium-chain triglyceride (MCT) diet as a treatment intervention.
• Seizure types included myoclonic, akinetic, focal motor, atypical absence, generalized tonic, and tonic-clonic seizures.

Main Results:

• Five patients (29%) achieved complete seizure control, allowing for reduction or cessation of anticonvulsant medications.
• An additional five patients (29%) experienced some improvement in seizure control.
• Two patients showed no change in seizure activity.
• Dietary adherence was challenging for two families, and three patients discontinued the diet due to side effects like diarrhea, vomiting, or irritability.

Conclusions:

• The medium-chain triglyceride (MCT) diet can be an effective treatment for various types of intractable seizures in children.
• This dietary intervention is generally well-tolerated and associated with few side effects.
• The MCT diet offers a potential therapeutic option for reducing or discontinuing antiepileptic drugs in pediatric epilepsy.